Fabian Model

Fabian Model is an experienced professional in biostatistics with a focus on neuroscience drug development. Currently serving as VP of Biometrics at Denali Therapeutics since May 2021, Fabian Model previously held various roles at Roche, including Director of Biostatistics, where leadership encompassed late-stage clinical development for multiple neurological conditions and neuroimmunology programs. Prior experience includes serving as Owner of ocCure GmbH, managing ovarian cancer diagnostics research, and working as a Biostatistician at Epigenomics AG, focusing on DNA methylation diagnostics. Academic credentials include a PhD in Biostatistics and a diploma in Technical Computer Science from Technische Universität Berlin.